Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

MGF Igf-1-ec

IGF-1Ec, IGF-1Eb, Mechano-Growth Factor

Quick Stats
Studies 62
Trials 100
Active Not Recruiting NA INTERVENTIONAL NCT06645119

Protein Ingestion on BMM Response in Endurance Runners

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

The goal of this clinical trial is to investigate the effects of protein ingestion post-exercise on bone turnover markers. The main questions it aims to answer is: Does protein ingestion independently influence the bone metabolic response to exercise in endurance runners? We will compare dietary protein to a placebo (water) to detect changes in bone turnover markers. Participants will: In a within-subject design, participants will perform an exhaustive run and take either protein or placebo immediately post-exercise. Track physical activity and diet before each arm of the intervention and during the washout period.

Detailed Description

Endurance athletes are at increased risk for bone loss and injury due to high-volume training, muscle weakness, and elevated nutritional demand. Dietary practices influence short- and long-term bone health and nutrition supplementation post-exercise may improve the short-term response of bone to exercise and benefit musculoskeletal recovery. However, we have a limited understanding of which dietary practices are most beneficial to optimize bone health in athletic populations. Protein supplementation has long been recommended for muscle adaptation and athletic performance but its potential for bone health has not been thoroughly investigated in endurance athletes. The purpose of this study is to is to investigate the acute independent effects of dietary protein ingestion on bone metabolism in healthy adults aged 18-35 years participating in high-volume endurance running.

Interventions

Name: Whey Protein Supplement
Type: DIETARY_SUPPLEMENT
Description: Examining the independent effect of post-exercise dietary protein ingestion on bone metabolic markers.

Primary Outcomes

Measure: Beta-C-terminal telopeptide
TimeFrame: Up to 24 hours
Description: Bone resorption marker
Measure: Procollagen 1 Intact N-Terminal Propeptide
TimeFrame: Up to 24 hours
Description: Bone formation marker

Trial Information

NCT ID

NCT06645119

Status

Active Not Recruiting

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

McGill University

Last Updated

December 15, 2025